Interdonato A, Choblet S, Sana M, Valgardsdottir R, Cribioli S, Alzani R, Roth M, Duonor-Cerutti M, Golay J
Cytotherapy (2022), 24(2), 161-171
Home / BL-01, an Fc-bearing, tetravalent CD20 × CD5 bispecific antibody, redirects multiple immune cells to kill tumors in vitro and in vivo
Interdonato A, Choblet S, Sana M, Valgardsdottir R, Cribioli S, Alzani R, Roth M, Duonor-Cerutti M, Golay J
Cytotherapy (2022), 24(2), 161-171
Nerviano Medical Sciences S.r.l.
Viale Luigi Pasteur 10
20014 Nerviano (MI)
Italy
Share Capital: € 1,200,000.00
fully paid-in
Company subject to the management and coordination of NMS Group S.p.A.